Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
4,038,640
-
Shares change
-
+886,240
-
Total reported value, excl. options
-
$6,625,021
-
Value change
-
+$1,453,711
-
Number of buys
-
8
-
Number of sells
-
-4
-
Price
-
$1.64
Significant Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q3 2020
16 filings reported holding BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share as of Q3 2020.
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,038,640 shares
of 2,048,819,940 outstanding shares and own 0.2% of the company stock.
Largest 10 shareholders include BVF INC/IL (1,686,375 shares), MORGAN STANLEY (768,335 shares), KENNEDY CAPITAL MANAGEMENT, INC. (695,552 shares), Senvest Management, LLC (331,205 shares), RENAISSANCE TECHNOLOGIES LLC (267,274 shares), Psagot Investment House Ltd. (117,000 shares), ORBIMED ADVISORS LLC (69,240 shares), Cutter & CO Brokerage, Inc. (29,000 shares), GOLDMAN SACHS GROUP INC (23,916 shares), and LPL Financial LLC (16,876 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.